Gilbert Tucat

958 total citations
26 papers, 591 citations indexed

About

Gilbert Tucat is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, Gilbert Tucat has authored 26 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 10 papers in Genetics and 9 papers in Surgery. Recurrent topics in Gilbert Tucat's work include Inflammatory Bowel Disease (10 papers), Microscopic Colitis (8 papers) and Gastrointestinal disorders and treatments (3 papers). Gilbert Tucat is often cited by papers focused on Inflammatory Bowel Disease (10 papers), Microscopic Colitis (8 papers) and Gastrointestinal disorders and treatments (3 papers). Gilbert Tucat collaborates with scholars based in France, Hungary and United States. Gilbert Tucat's co-authors include Anne‐Marie Bouvier, Philippe Godeberge, Jean‐Pierre Hugot, Jean‐Louis Dupas, Laurent Beaugerie, Fabrice Carrat, Marc Lémann, Stéphane Nahon, Jean–Frédéric Colombel and Kiarash Khosrotehrani and has published in prestigious journals such as Gastroenterology, Alimentary Pharmacology & Therapeutics and Endoscopy.

In The Last Decade

Gilbert Tucat

25 papers receiving 578 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gilbert Tucat France 7 429 365 184 109 70 26 591
Philippe Godeberge France 13 346 0.8× 297 0.8× 315 1.7× 89 0.8× 99 1.4× 25 687
Sarathchandra I. Reddy United States 10 456 1.1× 357 1.0× 193 1.0× 215 2.0× 52 0.7× 15 672
Daniel Sjöberg Sweden 13 373 0.9× 371 1.0× 244 1.3× 44 0.4× 40 0.6× 25 605
Manuel Van Domselaar Spain 10 374 0.9× 292 0.8× 177 1.0× 133 1.2× 39 0.6× 25 541
María Dolores Martin‐Arranz Spain 13 384 0.9× 248 0.7× 254 1.4× 102 0.9× 63 0.9× 88 638
Jordi Gordillo Spain 16 470 1.1× 404 1.1× 227 1.2× 66 0.6× 40 0.6× 46 701
Gábor Mester Hungary 9 767 1.8× 641 1.8× 359 2.0× 89 0.8× 83 1.2× 20 869
Gianluca Andrisani Italy 15 390 0.9× 346 0.9× 220 1.2× 39 0.4× 85 1.2× 48 721
Aurora Bortoli Italy 10 241 0.6× 208 0.6× 213 1.2× 89 0.8× 93 1.3× 18 488
Adriaan A. van Bodegraven Netherlands 11 291 0.7× 208 0.6× 226 1.2× 139 1.3× 19 0.3× 29 554

Countries citing papers authored by Gilbert Tucat

Since Specialization
Citations

This map shows the geographic impact of Gilbert Tucat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilbert Tucat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilbert Tucat more than expected).

Fields of papers citing papers by Gilbert Tucat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilbert Tucat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilbert Tucat. The network helps show where Gilbert Tucat may publish in the future.

Co-authorship network of co-authors of Gilbert Tucat

This figure shows the co-authorship network connecting the top 25 collaborators of Gilbert Tucat. A scholar is included among the top collaborators of Gilbert Tucat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilbert Tucat. Gilbert Tucat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Flourié, Bernard, Hervé Hagège, Gilbert Tucat, et al.. (2013). Randomised clinical trial: once‐ vs. twice‐daily prolonged‐release mesalazine for active ulcerative colitis. Alimentary Pharmacology & Therapeutics. 37(8). 767–775. 57 indexed citations
3.
Flourié, Bernard, Hervé Hagège, Gilbert Tucat, et al.. (2012). 1097 Once-Daily Versus Twice-Daily Mesalazine for Active Ulcerative Colitis: Efficacy Results From MOTUS, a Multicentre, Controlled, Randomised, Investigator-Blinded Study. Gastroenterology. 142(5). S–197. 4 indexed citations
5.
Flourié, Bernard, Hervé Hagège, Gilbert Tucat, et al.. (2012). P183 Once-daily versus twice-daily mesalazine for active ulcerative colitis: Efficacy results from MOTUS, a multicentre, controlled, randomised, investigator-blinded study. Journal of Crohn s and Colitis. 6. S82–S82. 2 indexed citations
7.
Peyrin‐Biroulet, Laurent, Kiarash Khosrotehrani, Fabrice Carrat, et al.. (2011). Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease. Gastroenterology. 141(5). 1621–1628.e5. 345 indexed citations
8.
Peyrin‐Biroulet, Laurent, Kiarash Khosrotehrani, Fabrice Carrat, et al.. (2011). Risk of Squamous and Basal Cell Carcinomas in Patients With Inflammatory Bowel Disorders Exposed to Thiopurines: The CESAME National Cohort Study. Gastroenterology. 140(5). S–41. 2 indexed citations
9.
Hagège, Hervé, et al.. (2010). Results of a national survey on quality of life in inflammatory bowel diseases. Clinics and Research in Hepatology and Gastroenterology. 35(2). 117–124. 39 indexed citations
10.
Carrat, Fabrice, Philippe Seksik, Anne‐Marie Bouvier, et al.. (2010). 255 Aminosalicylates, Thiopurines and the Risk of Colorectal Cancer in Inflammatory Bowel Diseases: A Case-Control Study Nested in the CESAME Cohort. Gastroenterology. 138(5). S–47. 13 indexed citations
11.
Escourrou, J, René Laugier, D. Héresbach, et al.. (2009). Consensus en endoscopie digestive (CED). Acta Endoscopica. 39(2). 116–121. 2 indexed citations
12.
Beaugerie, Laurent, Philippe Seksik, Anne‐Marie Bouvier, et al.. (2009). 281 Thiopurine Therapy Is Associated with a Three-Fold Decrease in the Incidence of Advanced Colorectal Neoplasia in IBD Patients with Longstanding Extensive Colitis: Results from the CESAME Cohort. Gastroenterology. 136(5). A–54. 17 indexed citations
13.
Beaugerie, Laurent, Fabrice Carrat, Anne‐Marie Bouvier, et al.. (2008). 818 Excess Risk of Lymphoproliferative Disorders (LPD) in Inflammatory Bowel Diseases (IBD): Interim Results of the Cesame Cohort. Gastroenterology. 134(4). A–116. 25 indexed citations
14.
Barthet, Marc, Bertrand Napoléon, L. Palazzo, et al.. (2007). Management of cystic pancreatic lesions found incidentally. Endoscopy. 39(10). 926–928. 3 indexed citations
15.
Boyer, J., R. Laugier, Jean‐Pierre Arpurt, et al.. (2007). French Society of Digestive Endoscopy SFED guideline: monitoring of patients with Barrett’s esophagus. Endoscopy. 39(9). 840–842. 47 indexed citations
16.
Gay, G., Michel Delvaux, R. Laugier, et al.. (2006). L’entéroscopie à double ballon (EDB). Acta Endoscopica. 36(2). 198–200. 1 indexed citations
17.
Boyer, J., R. Laugier, Jean‐Pierre Arpurt, et al.. (2006). Diagnostic et surveillance de l’endobrachyœsophage. Acta Endoscopica. 36(S1). 456–460. 2 indexed citations
18.
Babany, G, Marc Bourlière, H Chevalier, et al.. (1999). [Do general practitioners want to manage chronic hepatitis C and take part in hepatitis C health networks? A national survey].. PubMed. 23(12). 1289–95. 5 indexed citations
19.
Tucat, Gilbert, et al.. (1980). [Multiple spleens without obvious cardiac abnormalities. Results of highly selective arteriography in one case (author's transl)].. PubMed. 61(1). 65–8. 1 indexed citations
20.
Wechsler, B., et al.. (1980). [Crohn's disease associated with Wegener's granulomatosis (author's transl)].. PubMed. 4(5). 356–61. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026